(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...

Glucotrack (GCTK) will participate in the FORGETDIABETES bionic pancreas initiative that will develop a long-term, automated insulin delivery ...

With an initial capitalisation of €58 million, the fund aims to overcome national barriers and provide strategic financial ...

EC announces investment in Europe’s journey towards 6G leadership bringing together vertical industries, academia and research institutions.

Bannered the Together Fund, the fund has an initial capitalization of €58M ($66M), with ambitions to grow to €100M ($113M), ...